ID   CNO6L_HUMAN             Reviewed;         555 AA.
AC   Q96LI5; Q9UF92;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 2.
DT   22-JUL-2015, entry version 112.
DE   RecName: Full=CCR4-NOT transcription complex subunit 6-like;
DE            EC=3.1.13.4;
DE   AltName: Full=Carbon catabolite repressor protein 4 homolog B;
GN   Name=CNOT6L; Synonyms=CCR4B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 208-555 (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   IDENTIFICATION, FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH
RP   CNOT1; CNOT3; CNOT7; CNOT8 AND CNOT9, TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF ASP-410; ASP-489 AND HIS-529.
RX   PubMed=17452450; DOI=10.1128/MCB.02304-06;
RA   Morita M., Suzuki T., Nakamura T., Yokoyama K., Miyasaka T.,
RA   Yamamoto T.;
RT   "Depletion of mammalian CCR4b deadenylase triggers elevation of the
RT   p27Kip1 mRNA level and impairs cell growth.";
RL   Mol. Cell. Biol. 27:4980-4990(2007).
RN   [5]
RP   CATALYTIC ACTIVITY, AND INTERACTION WITH TOB1.
RX   PubMed=18377426; DOI=10.1111/j.1349-7006.2008.00746.x;
RA   Miyasaka T., Morita M., Ito K., Suzuki T., Fukuda H., Takeda S.,
RA   Inoue J., Semba K., Yamamoto T.;
RT   "Interaction of antiproliferative protein Tob with the CCR4-NOT
RT   deadenylase complex.";
RL   Cancer Sci. 99:755-761(2008).
RN   [6]
RP   IDENTIFICATION IN THE CCR4-NOT COMPLEX, AND COMPOSITION OF THE
RP   CCR4-NOT COMPLEX.
RX   PubMed=19558367; DOI=10.1042/BJ20090500;
RA   Lau N.C., Kolkman A., van Schaik F.M., Mulder K.W., Pijnappel W.W.,
RA   Heck A.J., Timmers H.T.;
RT   "Human Ccr4-Not complexes contain variable deadenylase subunits.";
RL   Biochem. J. 422:443-453(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=21233283; DOI=10.1091/mbc.E10-11-0898;
RA   Mittal S., Aslam A., Doidge R., Medica R., Winkler G.S.;
RT   "The Ccr4a (CNOT6) and Ccr4b (CNOT6L) deadenylase subunits of the
RT   human Ccr4-Not complex contribute to the prevention of cell death and
RT   senescence.";
RL   Mol. Biol. Cell 22:748-758(2011).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 158-555 ALONE AND IN COMPLEX
RP   WITH AMP ANALOG AND POLY-A DNA, MUTAGENESIS OF GLU-240; ASP-489 AND
RP   HIS-529, COFACTOR, ACTIVE SITE, AND MAGNESIUM-BINDING SITES.
RX   PubMed=20628353; DOI=10.1038/emboj.2010.152;
RA   Wang H., Morita M., Yang X., Suzuki T., Yang W., Wang J., Ito K.,
RA   Wang Q., Zhao C., Bartlam M., Yamamoto T., Rao Z.;
RT   "Crystal structure of the human CNOT6L nuclease domain reveals strict
RT   poly(A) substrate specificity.";
RL   EMBO J. 29:2566-2576(2010).
CC   -!- FUNCTION: Has 3'-5' poly(A) exoribonuclease activity for synthetic
CC       poly(A) RNA substrate. Catalytic component of the CCR4-NOT complex
CC       which is one of the major cellular mRNA deadenylases and is linked
CC       to various cellular processes including bulk mRNA degradation,
CC       miRNA-mediated repression, translational repression during
CC       translational initiation and general transcription regulation.
CC       Additional complex functions may be a consequence of its influence
CC       on mRNA expression. May be involved in the deadenylation-dependent
CC       degradation of mRNAs through the 3'-UTR AU-rich element-mediated
CC       mechanism. Involved in deadenylation-dependent degradation of
CC       CDKN1B mRNA. Its mRNA deadenylase activity can be inhibited by
CC       TOB1. Mediates cell proliferation and cell survival and prevents
CC       cellular senescence. {ECO:0000269|PubMed:17452450,
CC       ECO:0000269|PubMed:21233283}.
CC   -!- CATALYTIC ACTIVITY: Exonucleolytic cleavage of poly(A) to 5'-AMP.
CC       {ECO:0000269|PubMed:18377426}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:20628353};
CC   -!- SUBUNIT: Component of the CCR4-NOT complex; distinct complexes
CC       seem to exist that differ in the participation of probably
CC       mutually exclusive catalytic subunits; the complex contains two
CC       deadenylase subunits, CNOT6 or CNOT6L, and CNOT7 or CNOT8.
CC       Interacts with NANOS2 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       A5YKK6:CNOT1; NbExp=2; IntAct=EBI-1046635, EBI-1222758;
CC       O75175:CNOT3; NbExp=2; IntAct=EBI-1046635, EBI-743073;
CC       P50616:TOB1; NbExp=3; IntAct=EBI-1046635, EBI-723281;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96LI5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96LI5-2; Sequence=VSP_030321, VSP_030322, VSP_030323;
CC   -!- TISSUE SPECIFICITY: Highly expressed in placenta, skeletal muscle,
CC       pancreas, testis and leukocytes. Weakly expressed in heart, spleen
CC       and thymus. {ECO:0000269|PubMed:17452450}.
CC   -!- MISCELLANEOUS: Depletion of CNOT6L causes cell growth defect.
CC   -!- SIMILARITY: Belongs to the CCR4/nocturin family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 4 LRR (leucine-rich) repeats. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK058188; BAB71707.1; -; mRNA.
DR   EMBL; AC104701; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133112; CAB61415.1; -; mRNA.
DR   CCDS; CCDS68731.1; -. [Q96LI5-1]
DR   PIR; T42705; T42705.
DR   RefSeq; NP_001273719.1; NM_001286790.1. [Q96LI5-1]
DR   RefSeq; NP_653172.2; NM_144571.2. [Q96LI5-1]
DR   UniGene; Hs.592519; -.
DR   PDB; 3NGN; X-ray; 2.40 A; A=158-555.
DR   PDB; 3NGO; X-ray; 2.20 A; A=158-555.
DR   PDB; 3NGQ; X-ray; 1.80 A; A=158-555.
DR   PDBsum; 3NGN; -.
DR   PDBsum; 3NGO; -.
DR   PDBsum; 3NGQ; -.
DR   ProteinModelPortal; Q96LI5; -.
DR   SMR; Q96LI5; 36-540.
DR   BioGrid; 128873; 20.
DR   DIP; DIP-46837N; -.
DR   IntAct; Q96LI5; 19.
DR   STRING; 9606.ENSP00000264903; -.
DR   PhosphoSite; Q96LI5; -.
DR   BioMuta; CNOT6L; -.
DR   DMDM; 166216089; -.
DR   MaxQB; Q96LI5; -.
DR   PaxDb; Q96LI5; -.
DR   PRIDE; Q96LI5; -.
DR   DNASU; 246175; -.
DR   Ensembl; ENST00000504123; ENSP00000424896; ENSG00000138767.
DR   GeneID; 246175; -.
DR   KEGG; hsa:246175; -.
DR   UCSC; uc003hks.3; human. [Q96LI5-1]
DR   UCSC; uc003hkt.1; human. [Q96LI5-2]
DR   CTD; 246175; -.
DR   GeneCards; GC04M078634; -.
DR   HGNC; HGNC:18042; CNOT6L.
DR   HPA; HPA042688; -.
DR   neXtProt; NX_Q96LI5; -.
DR   PharmGKB; PA38480; -.
DR   eggNOG; COG4886; -.
DR   GeneTree; ENSGT00550000074364; -.
DR   HOGENOM; HOG000294222; -.
DR   HOVERGEN; HBG052641; -.
DR   InParanoid; Q96LI5; -.
DR   KO; K12603; -.
DR   OrthoDB; EOG7JX35D; -.
DR   PhylomeDB; Q96LI5; -.
DR   TreeFam; TF323175; -.
DR   BRENDA; 3.1.13.4; 2681.
DR   Reactome; REACT_20514; Deadenylation of mRNA.
DR   ChiTaRS; CNOT6L; human.
DR   EvolutionaryTrace; Q96LI5; -.
DR   GenomeRNAi; 246175; -.
DR   NextBio; 91870; -.
DR   PRO; PR:Q96LI5; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; Q96LI5; -.
DR   CleanEx; HS_CNOT6L; -.
DR   ExpressionAtlas; Q96LI5; baseline and differential.
DR   Genevisible; Q96LI5; HS.
DR   GO; GO:0030014; C:CCR4-NOT complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004535; F:poly(A)-specific ribonuclease activity; TAS:Reactome.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW.
DR   GO; GO:0061157; P:mRNA destabilization; IEA:Ensembl.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome.
DR   GO; GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0010606; P:positive regulation of cytoplasmic mRNA processing body assembly; IMP:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; TAS:GOC.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 3.60.10.10; -; 1.
DR   InterPro; IPR005135; Endo/exonuclease/phosphatase.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   Pfam; PF03372; Exo_endo_phos; 1.
DR   Pfam; PF13855; LRR_8; 1.
DR   SUPFAM; SSF56219; SSF56219; 1.
DR   PROSITE; PS51450; LRR; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Exonuclease; Hydrolase; Leucine-rich repeat; Magnesium; Metal-binding;
KW   mRNA processing; Nuclease; Nucleus; Reference proteome; Repeat;
KW   RNA-mediated gene silencing; Transcription; Transcription regulation;
KW   Translation regulation.
FT   CHAIN         1    555       CCR4-NOT transcription complex subunit 6-
FT                                like.
FT                                /FTId=PRO_0000314587.
FT   REPEAT       57     78       LRR 1.
FT   REPEAT       80    101       LRR 2.
FT   REPEAT      103    125       LRR 3.
FT   REPEAT      126    148       LRR 4.
FT   REGION        1    152       Required for interaction with CNOT1,
FT                                CNOT3 and CNOT7.
FT   REGION      158    555       Nuclease domain.
FT   ACT_SITE    240    240       {ECO:0000305|PubMed:20628353}.
FT   ACT_SITE    489    489       {ECO:0000305|PubMed:20628353}.
FT   ACT_SITE    529    529       {ECO:0000305|PubMed:20628353}.
FT   METAL       240    240       Magnesium 1.
FT   METAL       410    410       Magnesium 2.
FT   METAL       412    412       Magnesium 2.
FT   METAL       529    529       Magnesium 2.
FT   VAR_SEQ     127    153       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_030321.
FT   VAR_SEQ     486    502       GVIDYIFYSKTHMNVLG -> VSGSLWAGVEIISDTSM
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_030322.
FT   VAR_SEQ     503    555       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_030323.
FT   MUTAGEN     240    240       E->A: No enzymatic activity.
FT                                {ECO:0000269|PubMed:20628353}.
FT   MUTAGEN     410    410       D->A: Loss of deadenylase activity.
FT                                {ECO:0000269|PubMed:17452450}.
FT   MUTAGEN     489    489       D->A: Loss of deadenylase activity.
FT                                {ECO:0000269|PubMed:17452450,
FT                                ECO:0000269|PubMed:20628353}.
FT   MUTAGEN     489    489       D->A: No enzymatic activity.
FT                                {ECO:0000269|PubMed:17452450,
FT                                ECO:0000269|PubMed:20628353}.
FT   MUTAGEN     529    529       H->A: Loss of deadenylase activity.
FT                                {ECO:0000269|PubMed:17452450,
FT                                ECO:0000269|PubMed:20628353}.
FT   MUTAGEN     529    529       H->A: No enzymatic activity.
FT                                {ECO:0000269|PubMed:17452450,
FT                                ECO:0000269|PubMed:20628353}.
FT   CONFLICT    439    439       R -> G (in Ref. 1; BAB71707).
FT                                {ECO:0000305}.
FT   STRAND      174    176       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      187    195       {ECO:0000244|PDB:3NGQ}.
FT   HELIX       199    201       {ECO:0000244|PDB:3NGQ}.
FT   TURN        204    206       {ECO:0000244|PDB:3NGQ}.
FT   HELIX       212    215       {ECO:0000244|PDB:3NGQ}.
FT   HELIX       217    231       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      234    242       {ECO:0000244|PDB:3NGQ}.
FT   HELIX       243    248       {ECO:0000244|PDB:3NGQ}.
FT   HELIX       250    256       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      259    266       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      268    270       {ECO:0000244|PDB:3NGN}.
FT   HELIX       274    278       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      281    288       {ECO:0000244|PDB:3NGQ}.
FT   TURN        289    291       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      292    301       {ECO:0000244|PDB:3NGQ}.
FT   HELIX       302    308       {ECO:0000244|PDB:3NGQ}.
FT   HELIX       314    318       {ECO:0000244|PDB:3NGQ}.
FT   TURN        319    322       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      326    334       {ECO:0000244|PDB:3NGQ}.
FT   HELIX       336    338       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      353    360       {ECO:0000244|PDB:3NGQ}.
FT   HELIX       365    367       {ECO:0000244|PDB:3NGO}.
FT   HELIX       368    386       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      405    410       {ECO:0000244|PDB:3NGQ}.
FT   HELIX       418    425       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      427    429       {ECO:0000244|PDB:3NGQ}.
FT   HELIX       433    435       {ECO:0000244|PDB:3NGQ}.
FT   HELIX       443    447       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      459    461       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      466    468       {ECO:0000244|PDB:3NGQ}.
FT   TURN        469    473       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      474    476       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      478    480       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      489    494       {ECO:0000244|PDB:3NGQ}.
FT   TURN        495    497       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      498    504       {ECO:0000244|PDB:3NGQ}.
FT   HELIX       509    514       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      519    522       {ECO:0000244|PDB:3NGN}.
FT   STRAND      527    529       {ECO:0000244|PDB:3NGQ}.
FT   STRAND      532    538       {ECO:0000244|PDB:3NGQ}.
SQ   SEQUENCE   555 AA;  63001 MW;  C6E94F1BAE222241 CRC64;
     MRLIGMPKEK YDPPDPRRIY TIMSAEEVAN GKKSHWAELE ISGRVRSLST SLWSLTHLTA
     LHLNDNYLSR IPPDIAKLHN LVYLDLSSNK LRSLPAELGN MVSLRELLLN NNLLRVLPYE
     LGRLFQLQTL GLKGNPLSQD ILNLYQDPDG TRKLLNFMLD NLAVHPEQLP PRPWITLKER
     DQILPSASFT VMCYNVLCDK YATRQLYGYC PSWALNWEYR KKGIMEEIVN CDADIISLQE
     VETEQYFTLF LPALKERGYD GFFSPKSRAK IMSEQERKHV DGCAIFFKTE KFTLVQKHTV
     EFNQVAMANS DGSEAMLNRV MTKDNIGVAV VLEVHKELFG AGMKPIHAAD KQLLIVANAH
     MHWDPEYSDV KLIQTMMFVS EVKNILEKAS SRPGSPTADP NSIPLVLCAD LNSLPDSGVV
     EYLSNGGVAD NHKDFKELRY NECLMNFSCN GKNGSSEGRI THGFQLKSAY ENNLMPYTNY
     TFDFKGVIDY IFYSKTHMNV LGVLGPLDPQ WLVENNITGC PHPHIPSDHF SLLTQLELHP
     PLLPLVNGVH LPNRR
//
